Environmental, Social And Governance Report

Overview

The report presents Hansoh Pharma's 2022 ESG performance across governance, environmental operations, talent, procurement, product responsibility and community health. It reports 86,744.57 tCO2e of Scope 1 and 2 emissions, 14,385.67 tCO2e of Scope 3 emissions, and 20,100.20 TCE of total energy consumption. Workforce disclosures include 10,523 employees, 100% training coverage and 50% female board representation, while the Board ESG Committee oversaw ESG matters. The company also reports six innovative medicines in the National Reimbursement Drug List and RMB 47,386,000 in philanthropic expenditure.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Publication date: 27 April 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview